A Phase 1 Study of CAL-101, An Isoform-Selective Inhibitor of Phosphatidylinositol 3-Kinase P110 delta, In Combination with Rituximab and/or Bendamustine In Patients with Relapsed or Refractory B-Cell Malignancies

作者:Flinn Ian W; Schreeder Marshall T; Wagner Johnston Nina; Boccia Ralph V; Leonard John P; Coutre Steven E; Holes Leanne M; Peterman Sissy; Yu Albert S
来源:52nd Annual Meeting of the American-Society-of-Hematology (ASH), 2010-12-04 to 2010-12-07.
  • 出版日期2010-11-19